(S (NP (NP (DT The) (NN organization) (CC and) (NN mining)) (PP (IN of) (NP (ADJP (ADJP (NN malaria) (JJ genomic)) (CC and) (ADJP (JJ post-genomic))) (NNS data)))) (VP (VBZ is) (ADJP (RB highly) (VBN motivated) (PP (IN by) (NP (DT the) (NN necessity) (S (VP (TO to) (VP (VB predict) (CC and) (VB characterize) (NP (NP (JJ new) (JJ biological) (NNS targets)) (CC and) (NP (JJ new) (NNS drugs)))))))))) (. .))
(S (S (NP (NNP Biological) (NNS targets)) (VP (VBP are) (VP (VBN sought) (PP (IN in) (NP (NP (DT a) (JJ biological) (NN space)) (VP (VBN designed) (PP (IN from) (NP (NP (DT the) (JJ genomic) (NNS data)) (PP (IN from) (NP (NNP Plasmodium) (NNP falciparum))))))))))) (, ,) (CC but) (S (VP (VBG using) (ADVP (RB also)) (NP (NP (DT the) (NNS millions)) (PP (IN of) (NP (NP (JJ genomic) (NNS data)) (PP (IN from) (NP (JJ other) (NNS species)))))))) (. .))
(S (NP (NN Drug) (NNS candidates)) (VP (VBP are) (VP (VBN sought) (PP (IN in) (NP (NP (DT a) (NN chemical) (NN space)) (VP (VBG containing) (NP (NP (DT the) (NNS millions)) (PP (IN of) (NP (NP (JJ small) (NNS molecules)) (VP (VBN stored) (PP (IN in) (NP (ADJP (JJ public) (CC and) (JJ private)) (NNS chemolibraries)))))))))))) (. .))
(S (NP (NNS Data) (NN management)) (VP (MD should) (ADVP (RB therefore)) (VP (VB be) (PP (IN as) (ADJP (JJ reliable) (CC and) (JJ versatile) (PP (IN as) (ADJP (JJ possible))))))) (. .))
(S (PP (IN In) (NP (DT this) (NN context))) (, ,) (NP (PRP we)) (VP (VBD examined) (NP (NP (NP (CD five) (NNS aspects)) (PP (IN of) (NP (NP (DT the) (NN organization) (CC and) (NN mining)) (PP (IN of) (NP (ADJP (ADJP (NN malaria) (JJ genomic)) (CC and) (ADJP (JJ post-genomic))) (NNS data)))))) (: :) (NP (LST (LS 1) (-RRB- -RRB-)) (NP (NP (DT the) (NN comparison)) (PP (IN of) (NP (NP (NN protein) (NNS sequences)) (PP (VBG including) (NP (ADVP (RB compositionally)) (NP (NP (JJ atypical) (NN malaria) (NNS sequences)) (, ,) (NP (LST (LS 2) (-RRB- -RRB-)) (NP (DT the) (NML (JJ high) (NN throughput)) (NN reconstruction)) (PP (IN of) (NP (JJ molecular) (NNS phylogenies) (PRN (, ,) (NP (CD 3)) (-RRB- -RRB-)))))) (NP (NP (DT the) (NN representation)) (PP (IN of) (NP (JJ biological) (NNS processes)))) (NP (NP (NP (ADJP (RB particularly) (JJ metabolic)) (NNS pathways)) (, ,) (NP-TMP (CD 4)) (-RRB- -RRB-)) (NP (DT the) (JJ versatile) (NNS methods)))))))) (S (VP (TO to) (VP (VB integrate) (NP (JJ genomic) (NNS data)))))) (, ,) (NP (JJ biological) (NNS representations)) (CC and) (NP (NP (JJ functional) (NN profiling)) (VP (VBN obtained) (PP (IN from) (NP (JJ X-omic) (NNS experiments))) (PP (IN after) (NP (NP (NP (NN drug) (NNS treatments)) (CC and) (NP (CD 5))) (-RRB- -RRB-) (NP (NP (NP (DT the) (NN determination) (CC and) (NN prediction)) (PP (IN of) (NP (NN protein) (NNS structures)))) (CC and) (NP (NP (PRP$ their) (JJ molecular) (NN docking)) (PP (IN with) (NP (NML (NN drug) (NN candidate)) (NNS structures))))))))))) (. .))
(S (VP (VBZ Progresses) (PP (IN toward) (NP (NP (DT a) (NN grid) (HYPH -)) (VP (VBN enabled) (SBAR (S (NP (JJ chemogenomic) (NN knowledge) (NN space)) (VP (VBP are) (VP (VBN discussed))))))))) (. .))
